In sharp contrast with this is the remarkably high sensitivity to PD-1 blockade in cHL, suggesting that the quality of neoantigen is as important as quantity in terms of responsiveness to ICIs in lymphoma. This evidence concerns the gene PDCD1 and lymphoma.